Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-038481
Filing Date
2021-02-11
Accepted
2021-02-11 16:18:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d62714dsc13g.htm SC 13G 40417
  Complete submission text file 0001193125-21-038481.txt   42030
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 STATE STREET 26TH FLOOR Boston MA 02109
Business Address 75 STATE STREET 26TH FLOOR Boston MA 02109 617-205-3500
American Well Corp (Subject) CIK: 0001393584 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92157 | Film No.: 21619927
SIC: 7389 Services-Business Services, NEC